Centro Infant, Department of Pediatrics, School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.
PLoS One. 2020 Jan 28;15(1):e0228022. doi: 10.1371/journal.pone.0228022. eCollection 2020.
Pertussis is an important public health problem worldwide, especially in infants. An increase in the incidence in many countries occurred after 2010, including Brazil. In 2013, dTpa vaccine was introduced in the Brazil national immunization schedule of pregnant women. The objective of this study was to evaluate the national trends in the incidence of pertussis in Brazil in children under 1 year old, and the impact of the introduction of dTpa vaccine during pregnancy.
The incidence of hospitalizations and non-hospitalized confirmed cases of pertussis in neonates (< 1 month age) and young infants (1 month-< 1 year age) were analyzed, comparing the incidence in pre maternal vaccination (2011-2013) with the post-vaccination (2015-2017). We used non-respiratory hospitalizations as comparison, during the same period. A database of the Brazilian Ministry of Health (DATASUS) was used to analyze cases from 2007 to 2017 and the subsets of 2011-2013 and 2015-2017, after Pertussis resurgence. The vaccination data was accessed through the link of the Information System of the National Immunization Program (pni.datasus.gov.br).
Between 2007 and 2017, 17,818 children under one year of age were hospitalized due to pertussis in Brazil. In the pre maternal vaccination period 2011-2013, the mean annual incidence of non-hospitalized confirmed cases of pertussis in children under 1 month was 722.2 / 100,000 and in the period of 2015-2017 the average was 377.3 / 100,000, representing a decrease of 47.7% [IRR 0.52 (0.46-0.59)]. At those periods of time, the average incidence per year for children of one month-< 1 year aged was 64.9 / 100,000 (2011-2013) and 29.3 / 100,000 (2015-2017) [IRR 0.45 (CI 0.29-0.69)].
Vaccination of pregnant woman coincides with the reduction in the number of cases of pertussis in children under 1 month of age from 2015. Immunization of pregnant woman seems to have an important impact on the prevention of the disease in young infants who have not yet received their own pertussis vaccine.
百日咳是全球一个重要的公共卫生问题,尤其是在婴儿中。包括巴西在内的许多国家的发病率在 2010 年后有所上升。2013 年,dTpa 疫苗被引入巴西孕妇国家免疫计划。本研究的目的是评估巴西 1 岁以下儿童百日咳的全国发病率趋势,以及怀孕期间接种 dTpa 疫苗的影响。
分析新生儿(<1 个月龄)和婴儿(1 个月-<1 岁)住院和非住院确诊百日咳病例,比较产妇接种前(2011-2013 年)和接种后(2015-2017 年)的发病率。同期我们使用非呼吸道住院作为比较。利用巴西卫生部(DATASUS)的数据库分析 2007 年至 2017 年以及 2011-2013 年和 2015-2017 年百日咳反弹期间的数据。疫苗接种数据通过国家免疫计划信息系统(pni.datasus.gov.br)链接获取。
2007 年至 2017 年间,巴西有 17818 名 1 岁以下儿童因百日咳住院。在产妇接种前的 2011-2013 年期间,1 个月以下儿童非住院确诊百日咳的年平均发病率为 722.2/10 万,而 2015-2017 年期间的平均发病率为 377.3/10 万,下降了 47.7%[发病率比(IRR)0.52(0.46-0.59)]。在此期间,1 个月至<1 岁儿童的年平均发病率为 64.9/10 万(2011-2013 年)和 29.3/10 万(2015-2017 年)[IRR 0.45(0.29-0.69)]。
2015 年,孕妇接种疫苗与 1 个月以下儿童百日咳病例数量减少有关。孕妇免疫接种似乎对预防尚未接种百日咳疫苗的婴幼儿疾病有重要影响。